Cargando…

A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism

The social motivation hypothesis of autism posits that autism spectrum disorder (ASD) is characterized by impaired motivation to seek out social experience early in life that interferes with the development of social functioning. This framework suggests that impaired mesolimbic dopamine function und...

Descripción completa

Detalles Bibliográficos
Autores principales: Zürcher, Nicole R., Walsh, Erin C., Phillips, Rachel D., Cernasov, Paul M., Tseng, Chieh-En J., Dharanikota, Ayarah, Smith, Eric, Li, Zibo, Kinard, Jessica L., Bizzell, Joshua C., Greene, Rachel K., Dillon, Daniel, Pizzagalli, Diego A., Izquierdo-Garcia, David, Truong, Kinh, Lalush, David, Hooker, Jacob M., Dichter, Gabriel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801430/
https://www.ncbi.nlm.nih.gov/pubmed/33431841
http://dx.doi.org/10.1038/s41398-020-01170-0
_version_ 1783635573125152768
author Zürcher, Nicole R.
Walsh, Erin C.
Phillips, Rachel D.
Cernasov, Paul M.
Tseng, Chieh-En J.
Dharanikota, Ayarah
Smith, Eric
Li, Zibo
Kinard, Jessica L.
Bizzell, Joshua C.
Greene, Rachel K.
Dillon, Daniel
Pizzagalli, Diego A.
Izquierdo-Garcia, David
Truong, Kinh
Lalush, David
Hooker, Jacob M.
Dichter, Gabriel S.
author_facet Zürcher, Nicole R.
Walsh, Erin C.
Phillips, Rachel D.
Cernasov, Paul M.
Tseng, Chieh-En J.
Dharanikota, Ayarah
Smith, Eric
Li, Zibo
Kinard, Jessica L.
Bizzell, Joshua C.
Greene, Rachel K.
Dillon, Daniel
Pizzagalli, Diego A.
Izquierdo-Garcia, David
Truong, Kinh
Lalush, David
Hooker, Jacob M.
Dichter, Gabriel S.
author_sort Zürcher, Nicole R.
collection PubMed
description The social motivation hypothesis of autism posits that autism spectrum disorder (ASD) is characterized by impaired motivation to seek out social experience early in life that interferes with the development of social functioning. This framework suggests that impaired mesolimbic dopamine function underlies compromised responses to social rewards in ASD. Although this hypothesis is supported by functional magnetic resonance imaging (fMRI) studies, no molecular imaging study has evaluated striatal dopamine functioning in response to rewards in ASD. Here, we examined striatal functioning during monetary incentive processing in ASD and controls using simultaneous positron emission tomography (PET) and fMRI. Using a bolus + infusion protocol with the D2/D3 dopamine receptor antagonist [(11)C]raclopride, voxel-wise binding potential (BP(ND)) was compared between groups (controls = 12, ASD = 10) in the striatum. Striatal clusters showing significant between-group BP(ND) differences were used as seeds in whole-brain fMRI general functional connectivity analyses. Relative to controls, the ASD group demonstrated decreased phasic dopamine release to incentives in the bilateral putamen and left caudate, as well as increased functional connectivity between a PET-derived right putamen seed and the precuneus and insula. Within the ASD group, decreased phasic dopamine release in the putamen was related to poorer theory-of-mind skills. Our findings that ASD is characterized by impaired striatal phasic dopamine release to incentives provide support for the social motivation hypothesis of autism. PET-fMRI may be a suitable tool to evaluate novel ASD therapeutics targeting the striatal dopamine system.
format Online
Article
Text
id pubmed-7801430
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78014302021-01-21 A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism Zürcher, Nicole R. Walsh, Erin C. Phillips, Rachel D. Cernasov, Paul M. Tseng, Chieh-En J. Dharanikota, Ayarah Smith, Eric Li, Zibo Kinard, Jessica L. Bizzell, Joshua C. Greene, Rachel K. Dillon, Daniel Pizzagalli, Diego A. Izquierdo-Garcia, David Truong, Kinh Lalush, David Hooker, Jacob M. Dichter, Gabriel S. Transl Psychiatry Article The social motivation hypothesis of autism posits that autism spectrum disorder (ASD) is characterized by impaired motivation to seek out social experience early in life that interferes with the development of social functioning. This framework suggests that impaired mesolimbic dopamine function underlies compromised responses to social rewards in ASD. Although this hypothesis is supported by functional magnetic resonance imaging (fMRI) studies, no molecular imaging study has evaluated striatal dopamine functioning in response to rewards in ASD. Here, we examined striatal functioning during monetary incentive processing in ASD and controls using simultaneous positron emission tomography (PET) and fMRI. Using a bolus + infusion protocol with the D2/D3 dopamine receptor antagonist [(11)C]raclopride, voxel-wise binding potential (BP(ND)) was compared between groups (controls = 12, ASD = 10) in the striatum. Striatal clusters showing significant between-group BP(ND) differences were used as seeds in whole-brain fMRI general functional connectivity analyses. Relative to controls, the ASD group demonstrated decreased phasic dopamine release to incentives in the bilateral putamen and left caudate, as well as increased functional connectivity between a PET-derived right putamen seed and the precuneus and insula. Within the ASD group, decreased phasic dopamine release in the putamen was related to poorer theory-of-mind skills. Our findings that ASD is characterized by impaired striatal phasic dopamine release to incentives provide support for the social motivation hypothesis of autism. PET-fMRI may be a suitable tool to evaluate novel ASD therapeutics targeting the striatal dopamine system. Nature Publishing Group UK 2021-01-11 /pmc/articles/PMC7801430/ /pubmed/33431841 http://dx.doi.org/10.1038/s41398-020-01170-0 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Zürcher, Nicole R.
Walsh, Erin C.
Phillips, Rachel D.
Cernasov, Paul M.
Tseng, Chieh-En J.
Dharanikota, Ayarah
Smith, Eric
Li, Zibo
Kinard, Jessica L.
Bizzell, Joshua C.
Greene, Rachel K.
Dillon, Daniel
Pizzagalli, Diego A.
Izquierdo-Garcia, David
Truong, Kinh
Lalush, David
Hooker, Jacob M.
Dichter, Gabriel S.
A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism
title A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism
title_full A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism
title_fullStr A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism
title_full_unstemmed A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism
title_short A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism
title_sort simultaneous [(11)c]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801430/
https://www.ncbi.nlm.nih.gov/pubmed/33431841
http://dx.doi.org/10.1038/s41398-020-01170-0
work_keys_str_mv AT zurchernicoler asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT walsherinc asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT phillipsracheld asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT cernasovpaulm asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT tsengchiehenj asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT dharanikotaayarah asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT smitheric asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT lizibo asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT kinardjessical asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT bizzelljoshuac asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT greenerachelk asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT dillondaniel asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT pizzagallidiegoa asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT izquierdogarciadavid asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT truongkinh asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT lalushdavid asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT hookerjacobm asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT dichtergabriels asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT zurchernicoler simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT walsherinc simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT phillipsracheld simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT cernasovpaulm simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT tsengchiehenj simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT dharanikotaayarah simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT smitheric simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT lizibo simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT kinardjessical simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT bizzelljoshuac simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT greenerachelk simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT dillondaniel simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT pizzagallidiegoa simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT izquierdogarciadavid simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT truongkinh simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT lalushdavid simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT hookerjacobm simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism
AT dichtergabriels simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism